N-[11-(4-Chloro-phen-yl)-11,12-dihydro-benzo[c]phenanthridin-6-yl]benzamide.

about

N-[11-(4-Chloro-phen-yl)-11,12-dihydro-benzo[c]phenanthridin-6-yl]benzamide.

Item

http://www.wikidata.org/entity/Q41451322

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

N-[11-(4-Chloro-phen-yl)-11,12-dihydro-benzo[c]phenanthridin-6-yl]benzamide.

@en

type

Item

label

N-[11-(4-Chloro-phen-yl)-11,12-dihydro-benzo[c]phenanthridin-6-yl]benzamide.

@en

prefLabel

N-[11-(4-Chloro-phen-yl)-11,12-dihydro-benzo[c]phenanthridin-6-yl]benzamide.

@en

P1476

N-[11-(4-Chloro-phen-yl)-11,12-dihydro-benzo[c]phenanthridin-6-yl]benzamide.

@en

P2093

Liu-Qing Yang

http://www.w3.org/2001/XMLSchema#string

Min Zhang

http://www.w3.org/2001/XMLSchema#string

Xiang-Yang Wu

http://www.w3.org/2001/XMLSchema#string

P2860

A short history of SHELX

Benzo[c]phenanthridine bases and their antituberculosis activity.

Anti-tumour activities of a new benzo[c]phenanthridine agent, 2,3-(methylenedioxy)-5-methyl-7-hydroxy-8-methoxybenzo[c]phena nthridini um hydrogensulphate dihydrate (NK109), against several drug-resistant human tumour cell lines.

Inhibition of topoisomerase IIalpha and G2 cell cycle arrest by NK314, a novel benzo[c]phenanthridine currently in clinical trials.

Antimicrobial alkaloids from Zanthoxylum tetraspermum and caudatum.

A two-step synthesis of cytostatically active benzo[c]phenanthridine derivatives.

P304

o2973-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1107/S1600536810043485

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

Pt 11

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21589140

http://www.w3.org/2001/XMLSchema#string

P932

3009300

http://www.w3.org/2001/XMLSchema#string